Clinical Trials on Substance Use Disorders

Total 144583 results

University of Maryland, Baltimore

Withdrawn

Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder (SEARCH)

Opioid-use Disorder
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)

Completed

Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Intranasal Naltrexone and Naloxone

Opioid-use Disorder
Stony Brook University

Withdrawn

Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

Opioid-use Disorder
University of Vermont

Unknown

Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Opioid-use Disorder

United States
Indiana University

Completed

Implementation and Evaluation of SBIRT

Substance Use Disorders

United States
Kaiser Permanente
NORC at the University of Chicago; Agency for Healthcare Research and Quality... and other collaborators

Completed

Michigan SPARC Trial (MI-SPARC)

Alcohol Use Disorder (AUD) | Alcohol | Drinking

United States
University of Minnesota
National Institute on Drug Abuse (NIDA)

Completed

Functional Connectivity Changes During Early Recovery as a Marker for Relapse

Substance Use Disorder

United States
Mental Health Centre Sct. Hans

Not yet recruiting

VR Based Therapy to Treat Anxiety in Dual Diagnosis

Substance Use Disorder | Psychosis | Social Anxiety Disorder | Dual Diagnosis | Agoraphobia
Washington State University

Not yet recruiting

Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment (MIRROM)

Stimulant Use Disorder
William Stoops
National Institute on Drug Abuse (NIDA)

Recruiting

Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine) (BED IN 43)

Opioid Use Disorder | Cocaine Use Disorder

United States
Johns Hopkins University

Recruiting

Suvorexant for Opioid/Stimulant Co-use

Opioid Use Disorder | Stimulant Use Disorder

United States
Rowan University
The Cooper Health System

Recruiting

Increasing MAT Engagement With Financial Incentives

Opioid-use Disorder

United States
New York State Psychiatric Institute
Clinilabs, Inc.

Recruiting

Clinical Trials of Multivalent Opioid Vaccine Components

Opioid-use Disorder

United States
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
Allegheny Singer Research Institute (also known...
Abbott

Recruiting

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

Opioid-Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults

Opioid-use Disorder

United States
Mclean Hospital

Completed

Stress Response in Opioid Use Disorder

Opioid-use Disorder

United States
Denver Health and Hospital Authority
Centers for Disease Control and Prevention

Completed

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder (ConNECT)

Opioid-use Disorder

United States
Rutgers University

Completed

Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder

Opioid-use Disorder

United States
Yale University
Patient-Centered Outcomes Research Institute

Active, not recruiting

Treatment of Pregnant Women With OUD (SMART)

Opioid-use Disorder

United States
Michele Staton
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Kentucky Women's Justice Community Opioid Innovation Network (W-JCOIN)

Opioid-use Disorder

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

Pharmacokinetic Study of Vivitrol in Healthy Participants

Opioid-use Disorder

United States
Kaiser Permanente
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial (PROUD)

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
University of Delaware
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Completed

Disclosure Intervention for People in Recovery From Opioid Use Disorder

Opioid-use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

Opioid-use Disorder

United States
University of Minnesota

Active, not recruiting

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

Opioid Use Disorder | Stimulant Use Disorder

United States
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA); Dartmouth College; Kaiser Permanente; National...

Completed

Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder (D-TECT)

Opioid-use Disorder

United States
PhotoPharmics, Inc.
National Institute on Drug Abuse (NIDA); Brigham Young University

Completed

Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety

Opioid-use Disorder

United States
Laureate Institute for Brain Research, Inc.
Brain & Behavior Research Foundation

Completed

Frontoparietal Synchronization to Modulate Drug Craving in Opioid Use Disorder (FPS_Opioid)

Opioid-use Disorder

United States
Brigham and Women's Hospital

Completed

Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine (CURB)

Opioid-use Disorder

United States
Biomedical Development Corporation

Completed

mHealth for Patient Self-Management of Opioid Use Disorder

Opioid-use Disorder

United States
Q2i, LLC
National Institute on Drug Abuse (NIDA); University of California, Los Angeles

Enrolling by invitation

Technology for MAT in Primary Care - Phase 2

Opioid-use Disorder

United States
Brown University
National Institute on Drug Abuse (NIDA); University of Washington; UConn Health; RTI International

Active, not recruiting

Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics) (MIMIC)

Opioid-use Disorder

United States
CBT4CBT, LLC

Completed

CBT4CBT for Office Based Buprenorphine

Opioid-use Disorder

United States
Pear Therapeutics, Inc.
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene... and other collaborators

Completed

A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders

Opioid-use Disorder

United States
Nantes University Hospital
CSAPA Apsyades; OPPELIA-Le triangle

Completed

Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment (TOPAZE)

Opioid-use Disorder

France
Brigham and Women's Hospital

Withdrawn

Use of Transcranial Magnetic Stimulation to Reduce Craving for Individuals With Opioid Use Disorder Taking Buprenorphine

Opioid-use Disorder

United States
University of South Florida
Cambridge Health Alliance

Withdrawn

Effects of Remote Motivational Enhancement & MySafeRx on Post-Detox Engagement in B/N Treatment -RCT (MySafeRx)

Opioid-use Disorder

United States
Q2i, LLC
National Institute on Drug Abuse (NIDA); University of California, Los Angeles

Completed

Technology for MAT in Primary Care - Phase 1

Opioid-use Disorder

United States
New York State Psychiatric Institute

Terminated

Evaluation of Doxazosin to Alter the Abuse of Oxycodone

Opioid-use Disorder

United States
New York State Psychiatric Institute

Completed

Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder

Opioid-use Disorder

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Evaluating a Novel Medication Device for Methadone Dosing

Opioid-use Disorder

United States
Indivior Inc.

Completed

Evaluation of Long-term Buprenorphine Plasma Exposure

Opioid-use Disorder

United States
HealthPartners Institute
National Institute on Drug Abuse (NIDA); Hennepin Healthcare Research Institute

Completed

Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR (COMPUTE)

Opioid-use Disorder

United States
Lifespan
University of Rhode Island

Completed

Medication Maintenance Therapy in Community Pharmacy Settings (MATPharm)

Opioid-use Disorder

United States
Indiana University
National Institute on Drug Abuse (NIDA)

Recruiting

Maternal Brain Imaging in Opioid Use Disorder

Substance-Related Disorders | Pregnancy Related | Narcotic-Related Disorders | Substance Use | Opioid Use Disorder | Buprenorphine Dependence

United States

Clinical Trials on Substance Use Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations